These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27095456)

  • 21. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
    Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
    Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tn2008 is a major vehicle carrying bla(OXA-23) in Acinetobacter baumannii from China.
    Wang X; Zong Z; Lü X
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):218-22. PubMed ID: 21251570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of an outbreak of imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla(OXA-51-like) genes in a Korean hospital.
    Chaulagain BP; Jang SJ; Ahn GY; Ryu SY; Kim DM; Park G; Kim WY; Shin JH; Kook JK; Kang SH; Moon DS; Park YJ
    Jpn J Infect Dis; 2012; 65(2):162-6. PubMed ID: 22446125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing.
    Rafei R; Pailhoriès H; Hamze M; Eveillard M; Mallat H; Dabboussi F; Joly-Guillou ML; Kempf M
    BMC Microbiol; 2015 May; 15():103. PubMed ID: 25976451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.
    Ahmed SS; Alp E; Ulu-Kilic A; Dinc G; Aktas Z; Ada B; Bagirova F; Baran I; Ersoy Y; Esen S; Guven TG; Hopman J; Hosoglu S; Koksal F; Parlak E; Yalcin AN; Yilmaz G; Voss A; Melchers W
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1463-8. PubMed ID: 27259712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan.
    Chen TL; Lee YT; Kuo SC; Hsueh PR; Chang FY; Siu LK; Ko WC; Fung CP
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4575-81. PubMed ID: 20713680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China.
    He C; Xie Y; Fan H; Kang M; Tao C; Zhang R; Hu Y; Chen Z; Wang L
    Int J Antimicrob Agents; 2011 Sep; 38(3):257-60. PubMed ID: 21705198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.
    Sohrabi N; Farajnia S; Akhi MT; Nahaei MR; Naghili B; Peymani A; Amiri Z; Rezaee MA; Saeedi N
    Microb Drug Resist; 2012 Aug; 18(4):385-9. PubMed ID: 22352411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010.
    Ergin A; Hascelik G; Eser OK
    Scand J Infect Dis; 2013 Jan; 45(1):26-31. PubMed ID: 22978782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation.
    Ansaldi F; Canepa P; Bassetti M; Zancolli M; Molinari MP; Talamini A; Ginocchio F; Durando P; Mussap M; Orengo G; Viscoli C; Icardi G
    J Hosp Infect; 2011 Oct; 79(2):134-40. PubMed ID: 21820758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes.
    Hamouda A; Evans BA; Towner KJ; Amyes SG
    J Clin Microbiol; 2010 Jul; 48(7):2476-83. PubMed ID: 20421437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
    Wu W; He Y; Lu J; Lu Y; Wu J; Liu Y
    PLoS One; 2015; 10(9):e0137174. PubMed ID: 26340666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii.
    Hamidian M; Hall RM
    J Antimicrob Chemother; 2014 Jan; 69(1):77-80. PubMed ID: 23920428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
    Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.